For the Inventor, By the Inventor

Enter assignee name

Phoenix, AZ, United States of America

Visiongate, Inc.

USPTO Granted Patents = 35

% Expired Patents = 20.0

CIPO Patents = 18

EPO Patents = 10

Trademarks = 4

Forward Citations = 937

Loading Chart...

Loading Chart...

26 inventors (with patents filed for the assignee):

Alan C Nelson (24 out of 34 patents)

Michael G Meyer (15 out of 24 patents)

J Richard Rahn (10 out of 11 patents)

4. Mark Fauver (7 out of 20 patents)

5. Daniel J Sussman (7 out of 9 patents)

6. Jon W Hayenga (6 out of 33 patents)

7. Rahul Katdare (6 out of 6 patents)

8. Eric J Seibel (5 out of 63 patents)

9. Laimonas Kelbauskas (5 out of 5 patents)

10. Timothy Bell (4 out of 6 patents)

11. Randall Mastrangelo (4 out of 4 patents)

12. David Ethan Steinhauer (3 out of 3 patents)

13. Thomas Neumann (2 out of 8 patents)

14. John Richard Rahn (2 out of 3 patents)

15. Chee-Wui Chu (2 out of 2 patents)

Core Competencies:

Optical Tomography

Cell Classification

Morphometric Analysis

Tumor Detection

Liquid Biopsy

Dysplasia Monitoring

3D Imaging

Immunotherapy

Microscopic Velocity

Image Processing

Sample Enrichment

Flow Control

35 patents: Sort by Forward Citations

1. 12612663 - Morphometric detection of DNA mismatch repair deficiency (2026-04-28),

2. 12602781 - AI-based cell classification method and system (2026-04-14),

3. 12516380 - Morphometric genotyping of cells using optical tomography for detecting tumor mutational burden (2026-01-06),

4. 12399178 - Specimen enrichment for optical tomography cell analysis (2025-08-26),

5. 12019008 - Morphometric detection of malignancy associated change (2024-06-25),

6. 11885732 - Morphometric genotyping of cells in liquid biopsy using optical tomography (2024-01-30),

7. 11551043 - Morphometric detection of malignancy associated change (2023-01-10),

8. 11545237 - Morphometric genotyping of cells in liquid biopsy using optical tomography (2023-01-03),

9. 11069054 - System and method for automated detection and monitoring of dysplasia and administration of immunotherapy and chemotherapy (2021-07-20),

10. 10890595 - Method and apparatus for pre-positioning a radially symmetric, coaxial sample within a sheath fluid to provide uniform sample delivery rate during flow (2021-01-12),

11. 10753857 - Apparatus and method for measuring microscopic object velocities in flow (2020-08-25),

12. 9594072 - System and method for determining cell adequacy in a cytological analysis system (2017-03-14),

13. 8947510 - Functional imaging of cells with optical projection tomography (2015-02-03),

14. 8368035 - 3D imaging of live cells with ultraviolet radiation (2013-02-05),

15. 8254023 - Optical tomography system with high-speed scanner (2012-08-28),

Company Overview

Visiongate, Inc. is a pioneering company based in Phoenix, AZ, specializing in advanced medical technologies aimed at improving cancer diagnostics. The organization focuses on developing innovative solutions that leverage proprietary imaging and analysis techniques to enhance the detection and monitoring of lung cancer. By integrating cutting-edge research with practical applications, Visiongate aims to transform the landscape of early cancer detection, ultimately contributing to better patient outcomes and more effective treatment strategies.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

35 Patents

#25 in Phoenix, AZ

#115 in Arizona

#9,756 in US

#19,181 in the World

Phoenix, AZ, United States of America

Visiongate, Inc.

Forward Citations = 937

26 inventors:

Alan C Nelson (24 out of 34 patents)

Michael G Meyer (15 out of 24 patents)

J Richard Rahn (10 out of 11 patents)

4. Mark Fauver (7 out of 20 patents)

5. Daniel J Sussman (7 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Visiongate, Inc.. Retrieved from https://idiyas.com/company/visiongate

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…